NFE2L2 and obesity due to melanocortin 4 receptor deficiency: Furthermore, activation of NRF2 restricted only to muscle can lead to resistance to obesity and diabetes (Uruno et al., 2016; Matzinger et al., 2018), suggesting that metabolic consequences of NRF2 activation by genetics versus pharmacological tools differ across the tissues.